- Home
- HOLO vs MDCX Comparison
HOLO vs MDCX Comparison
Compare HOLO & MDCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HOLO | MDCX |
|---|---|---|
| Founded | 2018 | 2008 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | |
| Sector | Technology | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 52.2M | 53.4M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | HOLO | MDCX |
|---|---|---|
| Price | $3.05 | $1.56 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $23.50 |
| AVG Volume (30 Days) | ★ 478.2K | 349.6K |
| Earning Date | 01-01-0001 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 13.81 | N/A |
| Revenue | ★ $44,840,587.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $0.22 | ★ N/A |
| Revenue Growth | ★ 37.10 | N/A |
| 52 Week Low | $2.77 | $1.59 |
| 52 Week High | $370.00 | $8.94 |
Technical Indicators
Market Signals| Indicator | HOLO | MDCX |
|---|---|---|
| Relative Strength Index (RSI) | 39.99 | 33.69 |
| Support Level | $2.86 | $1.68 |
| Resistance Level | $3.20 | $2.03 |
| Average True Range (ATR) | 0.25 | 0.20 |
| MACD | -0.02 | -0.03 |
| Stochastic Oscillator | 18.27 | 1.41 |
Price Performance
Historical ComparisonAbout HOLO MicroCloud Hologram Inc.
MicroCloud Hologram Inc, through its subsidiaries, is mainly engaged in holographic Technology. It includes Holographic solutions and Holographic technology services. The company also provides holographic digital twin technology services for customers and has built a holographic digital twin technology resource library. Geographically company is operating in single segment, China.
About MDCX Medicus Pharma Ltd.
Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.